{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:52Z","timestamp":1792068892681,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    It is estimated 1.5 billion of the global population suffer from chronic pain with prevalence increasing with demographics including age. It is suggested long-term exposure to chronic could cause further health challenges reducing people\u2019s quality of life. Therefore, it is imperative to use effective treatment options. We explored the current pharmaceutical treatments available for chronic pain management to better understand drug efficacy and pain reduction. A systematic methodology was developed and published in PROSPERO (CRD42021235384). Keywords of opioids,\n                    <jats:italic>acute pain<\/jats:italic>\n                    ,\n                    <jats:italic>pain management<\/jats:italic>\n                    ,\n                    <jats:italic>chronic pain<\/jats:italic>\n                    ,\n                    <jats:italic>opiods<\/jats:italic>\n                    ,\n                    <jats:italic>NSAIDs<\/jats:italic>\n                    , and\n                    <jats:italic>analgesics<\/jats:italic>\n                    were used across PubMed, Science direct, ProQuest, Web of science, Ovid Psych INFO, PROSPERO, EBSCOhost, MEDLINE, ClinicalTrials.gov and EMBASE. All randomised controlled clinical trials (RCTs), epidemiology and mixed-methods studies published in English between the 1st of January 1990 and 30th of April 2022 were included. A total of 119 studies were included. The data was synthesised using a tri-partied statistical methodology of a meta-analysis (24), pairwise meta-analysis (24) and network meta-analysis (34). Mean, median, standard deviation and confidence intervals for various pain assessments were used as the main outcomes for pre-treatment pain scores at baseline, post-treatment pain scores and pain score changes of each group. Our meta-analysis revealed the significant reduction in chronic pain scores of patients taking NSAID versus non-steroidal opioid drugs was comparative to patients given placebo under a random effects model. Pooled evidence also indicated significant drug efficiency with Botulinum Toxin Type-A (BTX-A) and Ketamine. Chronic pain is a public health problem that requires far more effective pharmaceutical interventions with minimal better side-effect profiles which will aid to develop better clinical guidelines. The importance of understanding ubiquity of pain by clinicians, policy makers, researchers and academic scholars is vital to prevent social determinant which aggravates issue.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-49761-3","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T09:02:07Z","timestamp":1705568527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain"],"prefix":"10.1038","volume":"14","author":[{"given":"Ashish","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Delanerolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor","family":"Cavalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacson","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Qing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"49761_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","volume":"67","author":"J Dahlhamer","year":"2018","unstructured":"Dahlhamer, J. et al. Prevalence of chronic pain and high-impact chronic pain among adults: United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 67, 1001\u20131006. https:\/\/doi.org\/10.15585\/mmwr.mm6736a2 (2018).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"49761_CR2","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1097\/j.pain.0000000000002557","volume":"163","author":"Z Zimmer","year":"2022","unstructured":"Zimmer, Z., Fraser, K., Grol-Prokopczyk, H. & Zajacova, A. A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors: Examining the role of country-level contextual factors. Pain 163, 1740\u20131750 (2022).","journal-title":"Pain"},{"key":"49761_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2288-6-54","volume":"6","author":"CA Brown","year":"2006","unstructured":"Brown, C. A. & Lilford, R. J. The stepped wedge trial design: A systematic review. BMC Med. Res. Methodol. 6, 54. https:\/\/doi.org\/10.1186\/1471-2288-6-54 (2006).","journal-title":"BMC Med. Res. Methodol."},{"key":"49761_CR4","volume-title":"Biopsychosocial Perspective on Chronic Pain. Psychological Approaches to Pain Management: A Practitioner\u2019s Handbook","author":"DC Turk","year":"2002","unstructured":"Turk, D. C. & Monarch, E. S. Biopsychosocial Perspective on Chronic Pain. Psychological Approaches to Pain Management: A Practitioner\u2019s Handbook 2nd edn. (Guilford, 2002).","edition":"2"},{"key":"49761_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1741-7015-9-79","volume":"9","author":"T Li","year":"2011","unstructured":"Li, T. et al. Network meta-analysis-highly attractive but more methodological research is needed. BMC Med. 9, 79. https:\/\/doi.org\/10.1186\/1741-7015-9-79 (2011).","journal-title":"BMC Med."},{"key":"49761_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"D Caldwell","year":"2005","unstructured":"Caldwell, D., Ades, A. & Higgins, J. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ 331, 897\u2013900. https:\/\/doi.org\/10.1136\/bmj.331.7521.897 (2005).","journal-title":"BMJ"},{"key":"49761_CR7","unstructured":"Opioid Overdose. Who.int. www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose."},{"key":"49761_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00043-3","volume":"7","author":"Opioid","year":"2022","unstructured":"Opioid. Opioid overdose crisis: Time for a radical rethink. Lancet Public Health 7, e195 (2022).","journal-title":"Lancet Public Health"},{"issue":"10028","key":"49761_CR9","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame, S. et al. Use of and barriers to access to opioid analgesics: A worldwide, regional, and national study. Lancet. 387(10028), 1644\u20131656. https:\/\/doi.org\/10.1016\/S0140-6736(16)00161-6 (2016).","journal-title":"Lancet."},{"issue":"4","key":"49761_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","volume":"14","author":"JP Jansen","year":"2011","unstructured":"Jansen, J. P. et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR task force on indirect treatment comparisons good research practices: Part 1. Value Health. 14(4), 417\u2013428 (2011).","journal-title":"Value Health."},{"issue":"3","key":"49761_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jrsm.1195","volume":"7","author":"O Efthimiou","year":"2016","unstructured":"Efthimiou, O. et al. GetReal in network meta-analysis: A review of the methodology. Res. Synth. Methods. 7(3), 236\u2013263 (2016).","journal-title":"Res. Synth. Methods."},{"key":"49761_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2307\/1416740","volume":"52","author":"KM Dallenbach","year":"1939","unstructured":"Dallenbach, K. M. Pain: History and present status. Am. J. Psychol. 52, 331 (1939).","journal-title":"Am. J. Psychol."},{"key":"49761_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jclinane.2018.12.043","volume":"55","author":"JL Levene","year":"2019","unstructured":"Levene, J. L. et al. Local anesthetics and regional anesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children: A Cochrane systematic review and meta-analysis update. J. Clin. Anesth. 55, 116\u2013127 (2019).","journal-title":"J. Clin. Anesth."},{"key":"49761_CR14","unstructured":"Campbell, J. (1996, November 11). Presidential Address. Speech given at the American Pain Society, Washington, DC."},{"key":"49761_CR49","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","journal-title":"BMJ"},{"key":"49761_CR15","unstructured":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. (National Academies Press, 2011)."},{"key":"49761_CR16","unstructured":"Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. (U. S. Department of Health and Human Services, 2019). https:\/\/www.hhs.gov\/ash\/advisory-committees\/pain\/reports\/index.html."},{"key":"49761_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein, M., Hedges, L. V., Higgins, J. P. & Rothstein, H. R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods 1, 97\u2013111 (2010).","journal-title":"Res. Synth. Methods"},{"key":"49761_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/0470870168","volume-title":"Publication Bias in Meta Analysis: Prevention, Assessment and Adjustments","author":"HR Rothstein","year":"2005","unstructured":"Rothstein, H. R., Sutton, A. J. & Borenstein, M. Publication Bias in Meta Analysis: Prevention, Assessment and Adjustments (Wiley, 2005)."},{"key":"49761_CR19","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","volume":"320","author":"JW Busse","year":"2018","unstructured":"Busse, J. W. et al. Opioids for chronic noncancer pain: A systematic review and meta-analysis: A systematic review and meta-analysis. JAMA 320, 2448\u20132460 (2018).","journal-title":"JAMA"},{"key":"49761_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T. & Chou, R. CDC clinical practice guideline for prescribing opioids for pain: United States, 2022. MMWR Recomm. Rep. 71, 1\u201395 (2022).","journal-title":"MMWR Recomm. Rep."},{"key":"49761_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/pds.1833","volume":"18","author":"D Boudreau","year":"2009","unstructured":"Boudreau, D. et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol. Drug Saf. 18, 1166\u20131175 (2009).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"49761_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bja.2022.05.031","volume":"129","author":"A Noori","year":"2022","unstructured":"Noori, A. et al. Comparative benefits and harms of individual opioids for chronic non-cancer pain: A systematic review and network meta-analysis of randomised trials. Br. J. Anaesth. 129, 394\u2013406 (2022).","journal-title":"Br. J. Anaesth."},{"key":"49761_CR23","doi-asserted-by":"crossref","unstructured":"World Health Organization Model List of Essential Medicines: 22nd List, 2021. (WHO\/MHP\/HPS\/EML\/2021.02). (World Health Organization, 2021).","DOI":"10.1530\/ey.19.13.1"},{"key":"49761_CR24","volume-title":"Cancer Pain Relief, Second Edition, With a Guide to Opioid Availability","author":"World Health Organization","year":"1996","unstructured":"World Health Organization. Cancer Pain Relief, Second Edition, With a Guide to Opioid Availability (World Health Organization, 1996)."},{"key":"49761_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle, S. et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. BMJ 342, c7086 (2011).","journal-title":"BMJ"},{"key":"49761_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2321","volume":"375","author":"BR Da Costa","year":"2021","unstructured":"Da Costa, B. R. et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis. BMJ 375, n2321 (2021).","journal-title":"BMJ"},{"key":"49761_CR27","first-page":"012087","volume":"2","author":"WTM Enthoven","year":"2016","unstructured":"Enthoven, W. T. M., Roelofs, P. D. D. M., Deyo, R. A., van Tulder, M. W. & Koes, B. W. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst. Rev. 2, 012087 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"49761_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ejp.1941","volume":"26","author":"V Hary","year":"2022","unstructured":"Hary, V., Schitter, S. & Martinez, V. Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis. Eur. J. Pain 26, 980\u2013990 (2022).","journal-title":"Eur. J. Pain"},{"key":"49761_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41598-017-02209-x","volume":"7","author":"Z Meng","year":"2017","unstructured":"Meng, Z. et al. Tolerability of opioid analgesia for chronic pain: A network meta-analysis. Sci. Rep. 7, 1995 (2017).","journal-title":"Sci. Rep."},{"key":"49761_CR30","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni, A. et al. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol. 13, e58-68 (2012).","journal-title":"Lancet Oncol."},{"key":"49761_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jpainsymman.2017.07.025","volume":"54","author":"L Huang","year":"2017","unstructured":"Huang, L. et al. Opioid-induced constipation relief from fixed-ratio combination prolonged-release oxycodone\/naloxone compared with oxycodone and morphine for chronic nonmalignant pain: A systematic review and meta-analysis of randomized controlled trials. J. Pain Symp. Manage 54, 737-748.e3 (2017).","journal-title":"J. Pain Symp. Manage"},{"key":"49761_CR32","doi-asserted-by":"publisher","first-page":"18965","DOI":"10.1007\/s10067-022-06129-8","volume":"41","author":"FF Alberti","year":"2022","unstructured":"Alberti, F. F. et al. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: An overview with network meta-analysis. Clin. Rheumatol. 41, 18965\u201318978 (2022).","journal-title":"Clin. Rheumatol."},{"key":"49761_CR33","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2018.4222","volume":"178","author":"DM Urquhart","year":"2018","unstructured":"Urquhart, D. M. et al. Efficacy of low-dose amitriptyline for chronic low back pain: A randomized clinical trial: A randomized clinical trial. JAMA Intern. Med. 178, 1474\u20131481 (2018).","journal-title":"JAMA Intern. Med."},{"key":"49761_CR34","doi-asserted-by":"publisher","DOI":"10.4172\/pharmaceutical-sciences.1000274","author":"V Sankar","year":"2017","unstructured":"Sankar, V., Oommen, A. E., Thomas, A., Nair, J. V. & James, J. S. Efficacy, safety and cost effectiveness of amitriptyline and pregabalin in patients with diabetic peripheral neuropathy. Indian J. Pharm. Sci. https:\/\/doi.org\/10.4172\/pharmaceutical-sciences.1000274 (2017).","journal-title":"Indian J. Pharm. Sci."},{"key":"49761_CR35","first-page":"007938","volume":"6","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen, P. J. et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst. Rev. 6, 007938 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"49761_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002369","volume":"14","author":"H Shanthanna","year":"2017","unstructured":"Shanthanna, H. et al. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 14, e1002369 (2017).","journal-title":"PLoS Med."},{"key":"49761_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","volume":"77","author":"KE Evoy","year":"2017","unstructured":"Evoy, K. E., Morrison, M. D. & Saklad, S. R. Abuse and misuse of pregabalin and gabapentin. Drugs 77, 403\u2013426 (2017).","journal-title":"Drugs"},{"key":"49761_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011840","volume":"97","author":"C Jin","year":"2018","unstructured":"Jin, C., Chen, Z. & Zhang, J. Meta-analysis of the efficacy of Ningmitai capsule on the treatment of chronic prostatitis in China. Medicine 97, e11840 (2018).","journal-title":"Medicine"},{"key":"49761_CR39","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting, P. F. et al. Cannabinoids for medical use: A systematic review and meta-analysis: A systematic review and meta-analysis. JAMA 313, 2456\u20132473 (2015).","journal-title":"JAMA"},{"key":"49761_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1409","volume":"9","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials. Brain Behav. 9, e01409 (2019).","journal-title":"Brain Behav."},{"key":"49761_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.urology.2021.01.018","volume":"153","author":"K Zhang","year":"2021","unstructured":"Zhang, K. et al. Efficacy and safety of Ningmitai capsule in patients with chronic prostatitis\/chronic pelvic pain syndrome: A multicenter, randomized, double-blind, placebo-controlled trial. Urology 153, 264\u2013269 (2021).","journal-title":"Urology"},{"key":"49761_CR42","doi-asserted-by":"publisher","first-page":"9752592","DOI":"10.1155\/2021\/9752592","volume":"2021","author":"Z Jing","year":"2021","unstructured":"Jing, Z. et al. Efficacy and safety of Ningmitai capsules in patients with chronic epididymitis: A prospective, parallel randomized controlled clinical trial. Evid Based Complement. Altern. Med. 2021, 9752592 (2021).","journal-title":"Evid Based Complement. Altern. Med."},{"key":"49761_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.adaj.2016.08.022","volume":"147","author":"M Khalifeh","year":"2016","unstructured":"Khalifeh, M., Mehta, K., Varguise, N., Suarez-Durall, P. & Enciso, R. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome. J. Am. Dent. Assoc. 147, 959-973.e1 (2016).","journal-title":"J. Am. Dent. Assoc."},{"key":"49761_CR44","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1097\/SPV.0000000000000870","volume":"27","author":"MR Meister","year":"2021","unstructured":"Meister, M. R., Brubaker, A., Sutcliffe, S. & Lowder, J. L. Effectiveness of botulinum toxin for treatment of symptomatic pelvic floor myofascial pain in women: A systematic review and meta-analysis: A systematic review and meta-analysis. Female Pelvic. Med. Reconstr. Surg. 27, e152\u2013e160 (2021).","journal-title":"Female Pelvic. Med. Reconstr. Surg."},{"key":"49761_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/JPR.S358070","volume":"15","author":"JE Guimar\u00e3es Pereira","year":"2022","unstructured":"Guimar\u00e3es Pereira, J. E. et al. Efficacy and safety of ketamine in the treatment of neuropathic pain: A systematic review and meta-analysis of randomized controlled trials. J. Pain Res 15, 1011\u20131037 (2022).","journal-title":"J. Pain Res"},{"key":"49761_CR46","first-page":"47","volume":"1","author":"SP Cohen","year":"2018","unstructured":"Cohen, S. P. et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists. Reg. Anesth. Pain Med. 1, 47\u201350 (2018).","journal-title":"Reg. Anesth. Pain Med."},{"key":"49761_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","volume":"129","author":"V Orhurhu","year":"2019","unstructured":"Orhurhu, V., Orhurhu, M. S., Bhatia, A. & Cohen, S. P. Ketamine infusions for chronic pain: A systematic review and meta-analysis of randomized controlled trials. Anesth. Analg. 129, 241\u2013254 (2019).","journal-title":"Anesth. Analg."},{"key":"49761_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1213\/ANE.0000000000004673","volume":"131","author":"R Park","year":"2020","unstructured":"Park, R. et al. Efficacy and safety of magnesium for the management of chronic pain in adults: A systematic review. Anesth. Analg. 131, 764 (2020).","journal-title":"Anesth. Analg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49761-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T13:02:01Z","timestamp":1705842121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49761-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49761"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49761-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.23.23286360","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-3370201\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AS has received funding from Medtronic\u00a0and Nevro Corp USA. PP has received research grants from Novo Nordisk, Queen Mary University of London, John Wiley & Sons, Otsuka, outside the submitted work. AB has received\u00a0\u00a0speaker fees and has been an advisory board member from Pfizer, Vectura-Fertin and Reckitt. All other authors report no conflict of interest. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or the Academic institutions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1621"}}